Evidence map›Paper›PMID 38510267›Full record

ArticleFrontiers in oncology2023

Optically stimulated luminescence dosimeters for simultaneous measurement of point dose and dose-weighted LET in an adaptive proton therapy workflow.

Mislav Bobić, Jeppe B Christensen, Hoyeon Lee, Evangelia Choulilitsa, Katarzyna Czerska, Michele Togno, Sairos Safai, Eduardo G Yukihara, Brian A Winey, Antony J Lomax and 3 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mislav Bobić *Department of Physics, ETH Zurich, Zurich, Switzerland.
Jeppe B Christensen *Paul Scherrer Institute, Villigen, Switzerland.
Hoyeon LeeDepartment of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
Evangelia ChoulilitsaDepartment of Physics, ETH Zurich, Zurich, Switzerland.
Katarzyna CzerskaPaul Scherrer Institute, Villigen, Switzerland.
Michele TognoPaul Scherrer Institute, Villigen, Switzerland.
Sairos SafaiPaul Scherrer Institute, Villigen, Switzerland.
Eduardo G YukiharaPaul Scherrer Institute, Villigen, Switzerland.
Brian A WineyDepartment of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
Antony J LomaxDepartment of Physics, ETH Zurich, Zurich, Switzerland.
Harald PaganettiDepartment of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
Francesca AlbertiniPaul Scherrer Institute, Villigen, Switzerland.
Konrad P NesterukDepartment of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.

Funding

Project 3: Enhanced Sensitivity of Tumors to Proton Beam Therapy: Mechanisms and Biomarkers.P01CA261669 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI HONG, THEODORE S · 2021 to 2025
$14.0M
Fast Individualized Delivery Adaptation in Proton TherapyR01CA229178 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI PAGANETTI, HARALD · 2019 to 2023
$1.5M
NCI NIH HHS P01 CA261669NCI NIH HHS R01 CA229178
6 · The paper itself

Abstract

Purpose: To demonstrate the suitability of optically stimulated luminescence detectors (OSLDs) for accurate simultaneous measurement of the absolute point dose and dose-weighted linear energy transfer (LET Methods: A clinically realistic intensity-modulated proton therapy (IMPT) treatment plan was created based on a CT of an anthropomorphic head-and-neck phantom made of tissue-equivalent material. The IMPT plan was optimized with three fields to deliver a uniform dose to the target volume covering the OSLDs. Different scenarios representing inter-fractional anatomical changes were created by modifying the phantom. An online adaptive proton therapy workflow was used to recover the daily dose distribution and account for the applied geometry changes. To validate the adaptive workflow, measurements were performed by irradiating Al Results: The online adaptive proton therapy workflow was shown to recover significant degradation in dose conformity resulting from large anatomical and positioning deviations from the reference plan. The Monte Carlo simulations were in close agreement with the OSLD measurements, with an average relative error of 1.4% for doses and 3.2% for LET Conclusion: The OSLDs appear to be an excellent detector for simultaneously assessing dose and LET distributions in proton irradiation of an anthropomorphic phantom. The OSLDs can be cut to almost any size and shape, making them ideal for in-phantom measurements to probe the radiation quality and dose in a predefined region of interest. Although we have presented the results obtained in the experimental validation of an adaptive proton therapy workflow, the same approach can be generalized and used for a variety of clinical innovations and workflow developments that require accurate assessment of point dose and/or average LET.

Indexed as

adaptive proton therapyhead and neck phantomintensity-modulated proton therapyLET measurementMonte Carlooptically stimulated luminescenceOSLDproton therapy dosimetry

Identifiers

PMID38510267
PMCPMC10951997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.